Aemetis (NASDAQ:AMTX) Upgraded to “Sell” at StockNews.com

StockNews.com upgraded shares of Aemetis (NASDAQ:AMTX) to a sell rating in a report issued on Wednesday morning.

Several other analysts also recently commented on AMTX. Ascendiant Capital Markets reduced their target price on Aemetis from $20.00 to $19.00 and set a “buy” rating for the company in a research note on Tuesday, September 3rd. HC Wainwright reiterated a “buy” rating and issued a $28.00 price target on shares of Aemetis in a report on Monday, December 23rd. One investment analyst has rated the stock with a sell rating, one has given a hold rating and four have assigned a buy rating to the company. Based on data from MarketBeat.com, the company has an average rating of “Moderate Buy” and an average target price of $12.95.

Aemetis Stock Down 1.7 %

Shares of AMTX stock opened at $2.81 on Wednesday. The firm has a 50 day moving average of $3.29 and a 200-day moving average of $2.99. The company has a market cap of $139.76 million, a price-to-earnings ratio of -1.24 and a beta of 1.35. Aemetis has a 52 week low of $2.10 and a 52 week high of $7.03.

Aemetis (NASDAQ:AMTX) last posted its quarterly earnings results on Tuesday, November 12th. The specialty chemicals company reported ($0.38) EPS for the quarter, topping analysts’ consensus estimates of ($0.47) by $0.09. The company had revenue of $81.44 million during the quarter, compared to analyst estimates of $77.79 million. During the same quarter in the previous year, the business posted ($0.59) earnings per share. Analysts anticipate that Aemetis will post -2.02 earnings per share for the current year.

Institutional Investors Weigh In On Aemetis

Hedge funds and other institutional investors have recently made changes to their positions in the business. Barclays PLC boosted its stake in Aemetis by 274.6% during the 3rd quarter. Barclays PLC now owns 47,496 shares of the specialty chemicals company’s stock valued at $109,000 after purchasing an additional 34,816 shares during the last quarter. Geode Capital Management LLC lifted its holdings in shares of Aemetis by 7.7% in the third quarter. Geode Capital Management LLC now owns 924,293 shares of the specialty chemicals company’s stock valued at $2,126,000 after purchasing an additional 66,031 shares in the last quarter. Wellington Management Group LLP purchased a new position in shares of Aemetis during the third quarter valued at approximately $177,000. State Street Corp grew its holdings in Aemetis by 36.1% during the third quarter. State Street Corp now owns 699,089 shares of the specialty chemicals company’s stock worth $1,608,000 after buying an additional 185,304 shares in the last quarter. Finally, FMR LLC grew its holdings in Aemetis by 68.2% during the third quarter. FMR LLC now owns 22,531 shares of the specialty chemicals company’s stock worth $52,000 after buying an additional 9,137 shares in the last quarter. 27.02% of the stock is owned by institutional investors.

About Aemetis

Aemetis, Inc operates as a renewable natural gas and renewable fuels company. It operates through three segments: California Ethanol, California Dairy Renewable Natural Gas, and India Biodiesel. The company focuses on the operation, acquisition, development, and commercialization of technologies to produce low and negative carbon intensity renewable fuels that replace fossil-based products.